What would you like to eat, Mr CKD Microbiota? A mediterranean diet, please!

Kidney and Blood Pressure Research

Volumn 39, Issue 2-3, 2014, Pages 114-123

  Montemurno, Eustacchio ^a   Cosola, Carmela ^b   Dalfino, Giuseppe ^b   Daidone, Giuseppe ^c   De Angelis, Maria ^a   Gobbetti, Marco ^a   Gesualdo, Loreto ^a  

^a UNIVERSITY OF BARI   (Italy)

^b Centri Regionali per le Tecnologie Agroalimentari   (Italy)

^c Umberto I Hospital   (Italy)

Author keywords

Chronic Kidney Disease; Gut Microbiota; Mediterranean Diet; Western Diet

Indexed keywords

ANTIOXIDANT; UREMIC TOXIN;

CHRONIC KIDNEY DISEASE; DIET; DIGESTION; DISEASE ASSOCIATION; DISEASE COURSE; DYSBIOSIS; FERMENTATION; FOOD; HEALTH; HEALTH STATUS; HUMAN; IMMUNITY; INTESTINE FLORA; LARGE INTESTINE; MEDITERRANEAN DIET; MICROBIAL COMMUNITY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; WESTERN DIET; CHRONIC KIDNEY FAILURE; DIET THERAPY; MICROBIOLOGY; MICROFLORA;

DIET, MEDITERRANEAN; HUMANS; INTESTINE, LARGE; MICROBIOTA; RENAL INSUFFICIENCY, CHRONIC;

EID: 84906012965     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000355785     Document Type: Review

References (52)

1. Ruiz-Canela M, Martinez-Gonzalez MA: Lifestyle and dietary risk factors for peripheral artery disease. Circ J 2014;78:553-559.
2. Mekki K, Bouzidi-Bekada N, Kaddous A, Bouchenak M: Mediterranean diet improves dyslipidemia and biomarkers in chronic renal failure patients. Food Funct 2010;1:110.
3. Trichopoulou A, Kouris-Blazos A, Wahlqvist ML, Gnardellis C, Lagiou P, Polychronopoulos E, Vassilakou T, Lipworth L, Trichopoulos D: Diet and overall survival in elderly people. BMJ 1995; 311:1457-1460.
4. Martín-Pelá ez S, Covas MI, Fitó M, Ku?ar A, Pravst I: Health effects of olive oil polyphenols: Recent advances and possibilities for the use of health claims. Mol Nutr Food Res 2 013;57:760-771.
5. Ruiz-Canela M, Martinez-Gonzalez MA: Olive oil in the primary prevention of cardiovascular disease. Maturitas 2011;68:245-250.
6. Bouchenak M, Lam ri-Senhadji M: Nutritional Quality of Legumes, and Their Role in Cardiometabolic Risk Prevention: A Review. J Med Food 2013;16:185-198.
7. Nordmann AJ, Suter-Zimmermann K, Bucher HC, Shai I, Tuttle KR, Estruch R, Briel M: Meta-Analysis Comparing Mediterranean to Low-Fat Diets for Modification of Cardiovascular Risk Factors. Am J Med 2011;124:841-851.e842.
8. Zoetendal EG, de Vos WM: Effect of diet on the intestinal microbiota and its activity. Curr Opin Gastroenterol 2014;30:189-195.
9. Ramezani A, Raj DS: The Gut Microbiome, Kidney Disease, and Targeted Interventions. J Am Soc Nephrol 2014;25:657-670.
10. Carroll IM Threadgill DW Threadgill DS. The gastrointestinal microbiome: a malleable, third genome of mammals. Mamm Genome 2009 20 395-403.
11. Sekirov I, Russell SL, Antunes LCM, Finlay BB: Gut Microbiota in Health and Disease. Physiol Rev 2010;90:859-904.
12. Prakash S, Tomaro-Duchesneau C, Saha S, Cantor A: The gut microbiota and human health with an emphasis on the use of microencapsulated bacterial cells. J Biomed Biotechnol 2011;2011:981214.
13. Food and Agriculture Organization/World Health Organization: Carbohydrates in human nutrition: report of a Joint FAO/WHO expert consultation. FAO Food Nutr Paper 1998;66:1-140.
14. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI: Human nutrition, the gut microbiome and the immune system. Nature 2011;474:327-336.
15. Evenepoel P, Meijers BKI, Bammens BRM, Verbeke K: Uremic toxins originating from colonic microbial metabolism. Kidney Int 2009;76:S12-S19.
16. Hylemon PB, Zhou H, Pandak WM, Ren S, Gil G, Dent P: Bile acids as regulatory molecules. J Lipid Res 2009;50:1509-1520.
17. Prawitt J, Abdelkarim M, Stroeve JHM, Popescu I, Duez H, Velagapudi VR, Dumont J, Bouchaert E, Van Dijk TH, Lucas A, Dorchies E, Daoudi M, Lestavel S, Gonzalez FJ, Oresic M, Car iou B, Kuipers F, Caron S, Staels B: Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity. Diabetes 2011;60:1861-1871.
18. Scott KP, Gratz SW, Sheri dan PO, Flint HJ, Duncan SH: The influence of diet on the gut microbiota. Pharmacol Res 2013;69:52-60.
19. Tremaroli V, Backhed F: Functional interactions between the gut microbiota and host metabolism. Nature 2012;489:242-249.
20. Grenham S, Clarke G, Cryan JF, Dinan TG: Brain-gut-microbe communication in health and disease. Front Physiol 2011;2:94.
21. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R: Diversity, stability and resilience of the human gut microbiota. Nature 2012;489:220-230.
22. Harmsen HJM, Wildeboe r-Veloo ACM, Grijpstra J, Knol J, Degener JE, Welling GW: Development of 16S rRNA-Based Probes for theCoriobacterium Group and the Atopobium Cluster and Their Application for Enumeration of Coriobacteriaceaein Human Feces from Volunteers of Diff erent Age Groups. Appl Environ Microbiol 2000;66:4523-4527.
23. Sokol H, Lepage P, Seksik P, Dore J, Marteau P: Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escheri chia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol 2006;44:3172-3177.
24. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen Y-Y, Keilbaugh SA, Bewtra M, Knight s D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD: Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes. Science 2011;334:105-108.
25. Zimmer J, Lange B, Frick JS, Sauer H, Zimmermann K, Schwiertz A, Rusch K, Klosterhalfen S, Enck P: A vegan or vegetarian diet substantially alters the human colonic faecal microbiota . Eur J Clin Nutr 2012;66:53-60.
26. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutt on RJ, Turnbaugh PJ: Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014;505:559-563.
27. Vaziri ND, Yuan J, Rahimi A, Ni Z, Said H, Subramanian VS: Disint egration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol Dial Transplant 2012;27:2686-2693.
28. Vipperla K, O'Keefe SJ: The Microbiota and Its Metabolites in Colonic Mucosal Health and Cancer Risk. Nutr Clin Pract 2012;27:624-635.
29. Zhang Q-L, Rothenbacher D: Prevalence of chronic kidney disease in population-based studies: Systematic review. BMC Public Health 2008;8:117.
30. Filiopoulos V, Hadjiyannakos D, Takouli L, Metaxaki P, Sideris V, Vlassopoulos D: Inflammation and oxidative stress in end-stage renal disease patients treate d with hemodialysis or peritoneal dialysis. Int J Artif Organs 2009;32:872-882.
31. Tziomalos K, Ganotakis ES, Gazi IF, Nair DR, Mikhailidis DP: Kidney f unction and estimated vascular risk in patients with primary dyslipidemia. Open Cardiovasc Med J 2009;3:57-68.
32. McCarthy DD, Kujawa J, Wilson C, Papandile A, Poreci U, Porfilio EA, Ward L, Lawson MA, Macpherson AJ, McCoy KD, Pei Y, Novak L, Lee JY, Julian BA, Novak J, Ranger A, Gommerman JL, Browning JL: Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropat hy. J Clin Invest 2011;121:3991-4002.
33. Neish AS Microbes in gastrointestinal health and disease Gastroenterology 2009 136 65-80.
34. Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni ZM, Nguyen TH, Andersen GL: Chronic kidney disease alters intestinal microbial flora. Kidney International 2013;83:308-315.
35. Joyce SA, Gahan CG: The gut microbiota and the metabolic health of the host. Curr Opin Gastroenterol 2014;30:120-127.
36. Kalantar-Zadeh K, Kopple JD, Deepak S, Block D, Block G: Food intake cha racteristics of hemodialysis patients as obtained by food frequency questionnaire. J Ren Nutr 2002;12:17-31.
37. Poesen R, Meijers B, Evenepoel P: The colon: an overlooked site for therapeutics in dialysis patients. Semin Dial 2013;26:323-332.
38. Miyazaki T, Ise M, Seo H, Niwa T: Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys. Kidney Int 1997;52:S15-S22.
39. Vitetta L, Gobe G: Uremia and chronic kidney disease: The role of the gut microflora and therapies with pro-and prebiotics. Molec Nutr Food Res 2013;57:824-832.
40. Bammens B, Verbeke K, Vanrenterghem Y, Evenepoel P: Evidence for impaired assimilation of protein in chronic renal failure. Kidney Int 2003;64:2196-2203.
41. Meyer TW, Hostetter TH: Uremic solutes from colon microbes. Kidney Int 2012;81:949-954.
42. Vos MB: Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field. Curr Opin Lipidol 2014;25:61-66.
43. Marlow G, Ellett S, Ferguson IR, Zhu S, Karunasinghe N, Jesuthasan AC, Han DY, Fraser AG, Ferguson LR: Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn's disease patients. Hum Genomics 2013;7:24.
44. Ooi JH, Waddell A, Lin YD, Albert I, Rust LT, Holden V, Cantorna MT: Dominant effects of the diet on the microbiome and the local and systemic immune response in mice. Plos One 2014;9: e86366.
45. Ranganathan N, Ranganathan P, Friedman EA, Joseph A, Delano B, Goldfarb DS, Tam P, Rao AV, Anteyi E, Musso CG: Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patie nts with chronic kidney disease. Adv Ther 2010;27:634-647.
46. Chow KM, Liu ZC, Prakash S, Chang TM: Free and microencapsulated Lactobacillus and effects of metabolic induction on urea removal. Artif Cells Blood Substit Immobil Biotechnol 2003;31:425-434.
47. Ranganathan N, Patel B, Ranganathan P, Marczely J, Dheer R, Chordia T, Dunn SR, Friedman EA: Probiotic amelioration of azotemia in 5/6th nephrectomized Sprague-Dawley rats. ScientificWorldJournal 2005;5:652-660.
48. Taki K, Takayama F, Niwa T: Beneficial effects of Bifidobacteria in a gastroresistant seamless caps ule on hyperhomocysteinemia in hemodialysis patients. J Ren Nutr 2005;15:77-80.
49. Ogawa T, Shimada M, Nagano N, Ito K, Ando T, Shimomura Y, Ando Y, Otsuka K: Oral administration of Bifidobacterium longum in a gastro-resistant seamless capsule decreases serum phosphate levels in patients receiving haemodialysis. Clin Kidney J 2012;5:373-374.
50. Borody TJ, Brandt LJ, Paramsothy S: Therapeutic faecal microbiota transplantation: current status and future developments. Curr Opin Gastroenterol 2014;30:97-105.
51. Van Nood E, Speelman P, Nieuwdorp M, Keller J: Fecal microbiota transplantation: facts and controversies. Curr Opin Gastroenterol 2014;30:34-39.
52. Kinross J, Li JV, Muirhead LJ, Nicholson J: Nutritional modulation of the metabonome: applications of me tabolic phenotyping in translational nutritional research. Curr Opin Gastroenterol 2014;30:196-207.